お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
959622

抗バイオフィルム創傷ドレッシング材の世界市場 (2020-2027年):物理作用・化学作用・生物作用

Anti-biofilm Wound Dressing Market Size, Share & Trends Analysis Report By Mode Of Mechanism (Physical, Chemical, Biological), By Application, By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 90 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
抗バイオフィルム創傷ドレッシング材の世界市場 (2020-2027年):物理作用・化学作用・生物作用
出版日: 2020年08月19日
発行: Grand View Research, Inc.
ページ情報: 英文 90 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗バイオフィルム創傷ドレッシング材の市場規模は予測期間中9.1%のCAGRで推移し、2027年には11億米ドルの規模に成長すると予測されています。院内感染症 (HAI) の発生率の上昇、糖尿病、慢性疾患の有病率の拡大、火傷症例の増加、高齢者人口の増加などの要因が同市場の成長を推進しています。

当レポートでは、世界の抗バイオフィルム創傷ドレッシング材の市場を調査し、市場および製品の概要、COVID-19およびその他の市場影響因子の分析、市場規模の推移・予測、作用機序・用途・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査範囲

第2章 調査手法

第3章 調査目的

第4章 エグゼクティブサマリー

第5章 産業の展望

  • 普及・成長見通しマッピング
  • 法規制の枠組み
  • 市場力学
  • 市場分析ツール
  • COVID-19の影響

第6章 市場予測・動向分析:作用機序別

  • 物理作用
  • 化学作用
  • 生物作用

第7章 市場予測・動向分析:用途別

  • 慢性創傷
  • 急性創傷

第8章 市場予測・動向分析:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合分析

  • 企業プロファイル
    • ConvaTec
    • Smith & Nephew PLC
    • Urgo Medical
    • Coloplast
    • 3M
図表

List of Tables

  • Table 1 Primary interview details: North America
  • Table 2 Primary interview details: Europe
  • Table 3 Primary interview details: APAC
  • Table 4 Primary interview details: Latin America
  • Table 5 Primary interview details: MEA
  • Table 6 List of secondary sources
  • Table 7 List of abbreviation
  • Table 8 North America anti-biofilm wound dressing market, by country, USD million, 2015 - 2027
  • Table 9 North America anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 10 North America anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 11 The U.S anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 12 The U.S.anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 13 Canada anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 14 Canada anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 15 Europe anti-biofilm wound dressing market, by country, USD million, 2015 - 2027
  • Table 16 Europe anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 17 Europe anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 18 The U.K. anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 19 The U.K.anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 20 Germany anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 21 Germany anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 22 Asia Pacific anti-biofilm wound dressing market, by country, USD million, 2015 - 2027
  • Table 23 Asia Pacific anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 24 Asia Pacific anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 25 Japan anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 26 Japan anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 27 China anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 28 China anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 29 Latin America anti-biofilm wound dressing market, by country, USD million, 2015 - 2027
  • Table 30 Latin America anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 31 Latin America anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 32 Brazil anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 33 Brazil anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 34 Mexico anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 35 Mexico anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 36 Middle East & Africa anti-biofilm wound dressing market, by country, USD million, 2015 - 2027
  • Table 37 Middle East & Africa anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 38 Middle East & Africa anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 39 South Africa anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 40 South Africa anti-biofilm wound dressing market, by application, USD million, 2015 - 2027
  • Table 41 Saudi Arabia anti-biofilm wound dressing market, by mode of mechanism, USD million, 2015 - 2027
  • Table 42 Saudi Arabia anti-biofilm wound dressing market, by application, USD million, 2015 - 2027

List of Figures

  • Fig. 1 Anti-biofilm wound dressing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market summary (2019)
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Reimbursement pathway
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Anti-biofilm wound dressing market: Mode of mechanism movement analysis
  • Fig. 17 Anti-biofilm wound dressing market mode of mechanism outlook: Key takeaways
  • Fig. 18 Physical market, 2015 - 2027 (USD Million)
  • Fig. 19 Manual debridement market, 2015 - 2027 (USD Million)
  • Fig. 20 Pulse electrical field market, 2015 - 2027 (USD Million)
  • Fig. 21 Ultrasound debridement market, 2015 - 2027 (USD Million)
  • Fig. 22 Chemical market, 2015 - 2027 (USD Million)
  • Fig. 23 Ionic silver market, 2015 - 2027 (USD Million)
  • Fig. 24 Iodine market, 2015 - 2027 (USD Million)
  • Fig. 25 EDTA market, 2015 - 2027 (USD Million)
  • Fig. 26 Others market, 2015 - 2027 (USD Million)
  • Fig. 27 Biological market, 2015 - 2027 (USD Million)
  • Fig. 28 Dispersin B market, 2015 - 2027 (USD Million)
  • Fig. 29 Lactoferrin market, 2015 - 2027 (USD Million)
  • Fig. 30 Bacteriophage market, 2015 - 2027 (USD Million)
  • Fig. 31 Others market, 2015 - 2027 (USD Million)
  • Fig. 32 Anti-biofilm wound dressing market: Application movement analysis
  • Fig. 33 Anti-biofilm wound dressing market application outlook: Key takeaways
  • Fig. 34 Chronic wounds market, 2015 - 2027 (USD Million)
  • Fig. 35 Diabetic foot ulcers market, 2015 - 2027 (USD Million)
  • Fig. 36 Pressure ulcers market, 2015 - 2027 (USD Million)
  • Fig. 37 Venous leg ulcers market, 2015 - 2027 (USD Million)
  • Fig. 38 Other chronic wounds market, 2015 - 2027 (USD Million)
  • Fig. 39 Acute wounds market, 2015 - 2027 (USD Million)
  • Fig. 40 Surgical & traumatic wounds market, 2015 - 2027 (USD Million)
  • Fig. 41 Burn wounds market, 2015 - 2027 (USD Million)
  • Fig. 42 Regional Outlook, 2019 & 2027
  • Fig. 43 Regional market place: Key takeaways
  • Fig. 44 North America anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 45 The U.S. anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 46 Canada anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 47 Europe anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 48 The U.K. anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 49 Germany anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 50 Asia Pacific anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 51 Japan anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 52 China anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 53 Latin America anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 54 Brazil anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 55 Mexico anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 56 Middle East & Africa anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 57 South Africa anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
  • Fig. 58 Saudi Arabia anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
目次
Product Code: GVR-4-68038-948-7

Market Growth & Trends

The global anti-biofilm wound dressing market size is expected to reach USD 1.1 billion by 2027, expanding at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. The rising incidence of Hospital Acquired Infections (HAIs), growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.

Increasing the prevalence of chronic diseases across the globe is anticipated to drive the market. For instance, as per the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 366.0 million in 2011 to 552.0 million by 2030. Since prolonged diabetes leads to diabetic foot ulcers, thus, the rising prevalence of diabetes is expected to render a positive impact on market growth over the forecast period. The anti-biofilm wound dressing is very much effective in healing chronic injuries, thus, this factor is expected to propel the demand for the product. Furthermore, the increasing geriatric population across the globe is also anticipated to surge the market growth. For instance, as per the World Health Organization (WHO), the global geriatric population is anticipated to rise from 90.0 million in 2016 to 2.0 billion by 2050. Since the geriatric population is prone to chronic diseases and ulcers, thus growing geriatric population is also expected to surge market growth.

Increasing cases of accidents and trauma such as burns are expected to contribute to market growth. Traumatic events are most common in low and middle-income countries in comparison to high-income countries. Around 50.00% of people globally are exposed to fire-related traumas. For instance, as per the WHO, over 1,000,000 people are registered, annually, as moderately or severely burnt. Therefore, such an increase in the number of burn cases is projected to boost the demand for the products, thereby propelling the market growth over the forecast period.

Report Highlights:

  • In terms of revenue, the chemical mode of the mechanism segment held the largest share in 2019. Increase in the use of silver anti-biofilm wound dressing in chronic and acute injuries is the major factor driving the segment
  • Acute wounds segment held the largest market share in 2019 owing to the rising number of surgical procedures across the globe
  • Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to the rising number of surgeries and the presence of many local players.

Table of Contents

Chapter 1 Report Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline

Chapter 2 Research Methodology

  • 2.1 Research Methodology
    • 2.1.1 Information procurement
  • 2.2 Information or Data Analysis
  • 2.3 Market Formulation & Validation
  • 2.4 Region Wise Market Calculation
    • 2.4.1 Region Wise Market: Base Estimates
    • 2.4.2 Global Market: CAGR Calculation
  • 2.5 Region-Based Segment Share Calculation
  • 2.6 Model Details
    • 2.6.1 Commodity Flow Analysis (Model 1)
    • 2.6.2 Volume price analysis (Model 2)
  • 2.7 List of Secondary Sources

Chapter 3 Objectives

  • 3.1 Objective - 1:
  • 3.2 Objective - 2:
  • 3.3 Objective - 3:
  • 3.4 Objective - 4:

Chapter 4 Executive Summary

  • 4.1 Market Outlook
  • 4.2 Segment Outlook
  • 4.3 Competitive Insights
  • 4.4 Market Snapshot

Chapter 5 Industry Outlook

  • 5.1 Penetration & Growth Prospect Mapping
  • 5.2 Regulatory Framework
  • 5.3 Market Dynamics
    • 5.3.1 Market driver analysis
      • 5.3.1.1 Increasing incidence of chronic diseases
      • 5.3.1.2 Rising number of ambulatory surgery centers
      • 5.3.1.3 Increasing number of accidents
    • 5.3.2 Market restraint analysis
      • 5.3.2.1 Rising treatment costs
      • 5.3.2.2 Increasing use of advanced wound care products
  • 5.4 Anti-biofilm Wound Dressing Market Analysis Tools
    • 5.4.1 SWOT Analysis, by PEST
    • 5.4.2 Porter's five forces analysis
  • 5.5 Impact of COVID-19
    • 5.5.1 Supply chain
    • 5.5.2 Changing market trends

Chapter 6 Anti-biofilm Wound Dressing Market: Segment Analysis, By Mode of Mechanism, 2015 - 2027 (USD Million)

  • 6.1 Definitions & Scope
  • 6.2 Mode of Mechanism Market Share Analysis, 2019 & 2027
  • 6.3 Anti-biofilm Wound Dressing Market, by Mode opf Mechanism, 2015 to 2027
  • 6.4 Market Size Forecasts and Trend Analysis
    • 6.4.1 Physical
      • 6.4.1.1 Physical market, 2015 - 2027 (USD Million)
      • 6.4.1.2 Manual debridement
      • 6.4.1.2.1 Manual debridement market, 2015 - 2027 (USD Million)
      • 6.4.1.3 Pulse electrical field
      • 6.4.1.3.1 Pulse electrical field market, 2015 - 2027 (USD Million)
      • 6.4.1.4 Ultrasound debridement
      • 6.4.1.4.1 Ultrasound debridement market, 2015 - 2027 (USD Million)
    • 6.4.2 Chemical
      • 6.4.2.1 Chemical market, 2015 - 2027 (USD Million)
      • 6.4.2.2 Ionic silver
      • 6.4.2.2.1 Ionic silver market, 2015 - 2027 (USD Million)
      • 6.4.2.3 Iodine
      • 6.4.2.3.1 Iodine market, 2015 - 2027 (USD Million)
      • 6.4.2.4 EDTA
      • 6.4.2.4.1 EDTA market, 2015 - 2027 (USD Million)
      • 6.4.2.5 Others
      • 6.4.2.5.1 Others market, 2015 - 2027 (USD Million)
    • 6.4.3 Biological
      • 6.4.3.1 Biological market, 2015 - 2027 (USD Million)
      • 6.4.3.2 Dispersin B
      • 6.4.3.2.1 Dispersin B market, 2015 - 2027 (USD Million)
      • 6.4.3.3 Lactoferrin
      • 6.4.3.3.1 Lactoferrin market, 2015 - 2027 (USD Million)
      • 6.4.3.4 Bacteriophage
      • 6.4.3.4.1 Bacteriophage market, 2015 - 2027 (USD Million)
      • 6.4.3.5 Others
      • 6.4.2.5.1 Others market, 2015 - 2027 (USD Million)

Chapter 7 Anti-biofilm Wound Dressing Market: Segment Analysis, By Application, 2015 - 2027 (USD Million)

  • 7.1 Definitions & Scope
  • 7.2 Application Market Share Analysis, 2019 & 2027
  • 7.3 Anti-biofilm Wound Dressing Market, by Application, 2015 to 2027
  • 7.4 Market Size Forecasts and Trend Analysis
    • 7.4.1 Chronic wounds
      • 7.4.1.1 Chronic wounds market, 2015 - 2027 (USD Million)
      • 7.4.1.2 Diabetic foot ulcers
      • 7.4.1.2.1 Diabetic foot ulcers market, 2015 - 2027 (USD Million)
      • 7.4.1.3 Pressure ulcers
      • 7.4.1.3.1 Pressure ulcers market, 2015 - 2027 (USD Million)
      • 7.4.1.4 Venous leg ulcers
      • 7.4.1.4.1 Venous leg ulcers market, 2015 - 2027 (USD Million)
      • 7.4.1.5 Other chronic wounds
      • 7.4.1.5.1 Other chronic wounds market, 2015 - 2027 (USD Million)
    • 7.4.2 Acute wounds
      • 7.4.2.1 Acute wounds market, 2015 - 2027 (USD Million)
      • 7.4.2.2 Surgical & traumatic wounds
      • 7.4.2.2.1 Surgical & traumatic wounds market, 2015 - 2027 (USD Million)
      • 7.4.2.3 Burn wounds
      • 7.4.2.3.1 Burn wounds market, 2015 - 2027 (USD Million)

Chapter 8 Anti-biofilm Wound Dressing Market: Regional Market Analysis, By Mode of Mechanism and Application, 2015 - 2027 (USD Million)

  • 8.1 Definitions & Scope
  • 8.2 Regional Market Share Analysis, 2019 & 2027
  • 8.3 Regional Market Snapshot
  • 8.4 Market Size Forecasts & Trend Analysis
    • 8.4.1 North America
      • 8.4.1.1 North America anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.1.2 The U.S.
      • 8.4.1.2.1 U.S. anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.1.3 Canada
      • 8.4.1.3.1 Canada anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
    • 8.4.2 Europe
      • 8.4.2.1 Europe anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.2.2 The U.K.
      • 8.4.2.2.1 The U.K. anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.2.3 Germany
      • 8.4.2.3.1 Germany anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
    • 8.4.3 Asia Pacific
      • 8.4.3.1 Asia Pacific anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.3.2 Japan
      • 8.4.3.2.1 Japan anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.3.3 China
      • 8.4.3.3.1 China anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
    • 8.4.4 Latin America
      • 8.4.4.1 Latin America anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.4.2 Brazil
      • 8.4.4.2.1 Brazil anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.4.3 Mexico
      • 8.4.4.3.1 Mexico anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
    • 8.4.5 Middle East & Africa
      • 8.4.5.1 Middle East & Africa anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.5.2 South Africa
      • 8.4.5.2.1 South Africa anti-biofilm wound dressing market, 2015 - 2027 (USD Million)
      • 8.4.5.3 Saudi Arabia
      • 8.4.5.3.1 Saudi Arabia anti-biofilm wound dressing market, 2015 - 2027 (USD Million)

Chapter 9 Anti-biofilm Wound Dressing Market: Competitive Analysis

  • 9.1 Company Profiles
    • 9.1.1 ConvaTec
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial performance
      • 9.1.1.3 Product benchmarking
    • 9.1.2 Smith & Nephew PLC
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial performance
      • 9.1.2.3 Product benchmarking
      • 9.1.2.4 Strategic initiatives
    • 9.1.3 Urgo Medical
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial performance
      • 9.1.3.3 Product benchmarking
    • 9.1.4 Coloplast
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 3M
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial performance
      • 9.1.5.3 Product benchmarking
      • 9.1.5.4 Strategic initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.